November 21, 2026

Beximco Pharma debuts on London Stock Exchange Friday

Trading of global depository receipts (GDRs) of Beximco Pharmaceuticals begins on the Alternative Investment Market (AIM) of London Stock Exchange (LSE) Friday.

bdnews24.com News Service

bdnews24.com

Published : 19 Oct 2005, 06:00 PM

Updated : 18 Aug 2022, 12:09 PM

Dhaka, Oct 20 (BDNEWS) - Trading of global depository receipts (GDRs) of Beximco Pharmaceuticals begins on the Alternative Investment Market (AIM) of London Stock Exchange (LSE) Friday. Beximco Pharmaceuticals Ltd. (BPL), is supplying around 10% of the countries total medicine need, it also aggressively pursues internationalization of its business with ground presence in 19 countries across the globe. With this listing, the local pharmaceutical giant has positioned itself as the one and only national company from Bangladesh to raise fund from overseas stock market. The trading will commence after a ceremonial launching. Stephen Timms MP, Minister for the Department of Work and Pensions, House of Commons, United Kingdom, will be preset at the function while Sohel F Rahman, Chairman, Salman F Rahman, Vice-Chairman, Osman Kaiser Chowdhury, Director of Beximco group, Nazmul Hassan, Chief Executive Officer (CEO) of Beximco Pharma, Ali Nawaz, Director Finance of BPL, Rizvi-ul Kabir, Senior Manager Marketing of BPL and distinguished business personalities from home and abroad will be present to witness the inauguration of the trading. A total of 23 Bangladeshi journalists will also be present to mark the occasion. The books for subscription of the GDRs closed in London on October 6, 2005. A total of 2 crore GDRs have been issued to raise around Tk 142 crore from international institutional investors. The raised capital will be primarily utilized to build a new state-of-the-art multidisciplinary R&D facility and also to invest on new projects. "In addition, the company is expected to raise approximately another Tk 57 crore by issuing 6,666,662 GDR warrants to be issued to the subscribers of GDRs," according to the corporate announcement. Beximco Pharma won the national Export Trophy (Gold) for the record 3 times for its outstanding performance in the international markets. Salman F Rahman, Vice Chairman of Beximco Group said: "It's a historic occasion. Beximco Pharma's listing on London Stock Exchange will definitely introduce our country in new way, as we become the first and only company from Bangladesh listed in LSE, the first and only company among all the Islamic countries to be listed in LSE." The CEO of Beximco Pharma Nazmul Hassan said: "The Company's vision is to achieve significant business in branded generics market with a strong presence in developed countries. This listing in LSE is one step ahead in achieving this vision." Beximco Pharma, which reported a net income of around Tk 33 crore on sales of Tk 277 crore last year, plans to pump the raised money in research and development to innovate its own new drugs. Nazmul added that most countries that have joined the WTO have been forced to introduce tough procedures to respect product and process patents. BDNEWS/1813 hrs
Related Stories